Altrius Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.3M Buy
72,981
+2,854
+4% +$252K 1.12% 44
2026
Q2
$5.49M Buy
70,127
+12,702
+22% +$1.02M 1.04% 60
2026
Q1
$4.98M Buy
57,425
+1,590
+3% +$152K 0.99% 64
2025
Q4
$5.36M Buy
55,835
+1,245
+2% +$121K 1.14% 47
2025
Q3
$5.2M Buy
54,590
+662
+1% +$60.9K 1.19% 44
2025
Q2
$4.7M Buy
+53,928
New +$4.57M 1.1% 45

Other funds holding MDT

Altrius Capital Management's MDT Position: Q3 2026 in Review

Altrius Capital Management increased its Medtronic (MDT) stake by 4.1% in Q3 2026, buying an estimated $252K and bringing the position to 72,981 shares worth $6.3M. The position accounts for 1.12% of the portfolio, ranked #44.

Altrius Capital Management first reported a position in MDT in Q2 2025 and has held it in 6 quarters since. 1,271 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Altrius Capital Management held 72,981 shares of Medtronic worth $6.3M as of Q3 2026.
  • Altrius Capital Management bought 2,854 Medtronic shares in Q3 2026, an estimated $252K.
  • Medtronic made up 1.12% of Altrius Capital Management's portfolio in Q3 2026, its #44 holding.
  • Altrius Capital Management first reported a position in Medtronic in Q2 2025 and has held it in 6 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Altrius Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.